Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.780
+0.020 (1.14%)
At close: Jul 24, 2026, 4:00 PM EDT
1.740
-0.040 (-2.25%)
After-hours: Jul 24, 2026, 6:46 PM EDT
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $169.81 million as of July 24, 2026. Its market cap has decreased by -7.66% in one year.
Market Cap
169.81M
Enterprise Value
156.45M
1-Year Change
-7.66%
Ranking
Category
Stock Price
$1.78
ChartMarket Cap Chart
Since October 18, 2019, Innate Pharma's market cap has decreased from $480.08M to $169.81M, a decrease of -64.63%. That is a compound annual growth rate of -14.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 169.81M | -2.06% |
| Dec 31, 2025 | 173.38M | 4.71% |
| Dec 31, 2024 | 165.58M | -29.08% |
| Dec 29, 2023 | 233.49M | -17.19% |
| Dec 30, 2022 | 281.97M | -29.50% |
| Dec 31, 2021 | 399.94M | 19.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tenaya Therapeutics | 171.21M |
| Alector | 169.87M |
| Tonix Pharmaceuticals Holding | 168.81M |
| Korro Bio | 168.74M |
| Arcturus Therapeutics Holdings | 168.55M |
| LENZ Therapeutics | 167.43M |
| Kazia Therapeutics | 166.83M |
| Caribou Biosciences | 164.64M |